Terms: = Gastric cancer AND CD79A, ENSG00000105369, 973, P11912, MB-1, IGA AND Clinical Outcome
3 results:
1. Prognostic significance of MET amplification and expression in gastric cancer: a systematic review with meta-analysis.
Peng Z; Zhu Y; Wang Q; Gao J; Li Y; Li Y; Ge S; Shen L
PLoS One; 2014; 9(1):e84502. PubMed ID: 24416238
[TBL] [Abstract] [Full Text] [Related]
2. Metallothionein 2A inhibits NF-κB pathway activation and predicts clinical outcome segregated with TNM stage in gastric cancer patients following radical resection.
Pan Y; Huang J; Xing R; Yin X; Cui J; Li W; Yu J; Lu Y
J Transl Med; 2013 Jul; 11():173. PubMed ID: 23870553
[TBL] [Abstract] [Full Text] [Related]
3. Benefits of early postoperative enteral feeding in cancer patients.
Braga M; Vignali A; Gianotti L; Cestari A; Profili M; Di Carlo V
Infusionsther Transfusionsmed; 1995 Oct; 22(5):280-4. PubMed ID: 8924741
[TBL] [Abstract] [Full Text] [Related]
